Evidence map›Paper›PMID 24386491›Full record

Trial reportPloS one2013

Neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer receiving palliative chemotherapy: a randomized phase II study.

Matthew Maddocks, Vanessa Halliday, Alpna Chauhan, Victoria Taylor, Annmarie Nelson, Cathy Sampson, Anthony Byrne, Gareth Griffiths, Andrew Wilcock

Open access · goldAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 7 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 7 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Non-pharmacological interventions targeting mobility among people with advanced cancer: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  3. Pooled it
  4. Exercise training for advanced lung cancer.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. The efficacy and prescription of neuromuscular electrical stimulation (NMES) in adult cancer survivors: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Pooled it
  6. Understanding factors influencing physical activity and exercise in lung cancer: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Neuromuscular Electrical Stimulation Plus Nutritional Counseling Attenuates Thigh Muscle Thickness Loss in Hospitalized Cancer Patients.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. A longitudinal study of muscle strength and function in patients with cancer cachexia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  18. Article
  19. The application of neuromuscular electrical stimulation (NMES) in cancer rehabilitation: current prescription, pitfalls, and future directions.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Matthew MaddocksKings College London, Cicely Saunders Institute, Department of Palliative Care, Policy & Rehabilitation, London, United Kingdom ; Department of Palliative Medicine, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
Vanessa HallidaySchool of Biosciences, University of Nottingham, Nottingham, United Kingdom.
Alpna ChauhanKing's Mill Hospital, Sherwood Forest Hospitals National Health Service Foundation Trust, Sutton in Ashfield, United Kingdom.
Victoria TaylorDepartment of Palliative Medicine, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
Annmarie NelsonMarie Curie Research Centre and Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom.
Cathy SampsonMarie Curie Research Centre and Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom.
Anthony ByrneMarie Curie Research Centre and Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom.
Gareth GriffithsMarie Curie Research Centre and Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom.
Andrew WilcockDepartment of Palliative Medicine, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
Marie Curie · GBNational Health Service · GBCardiff University · GBNottingham University Hospitals NHS Trust · GBUniversity of Nottingham · GB

Funding

Cancer Research UK 15954Department of Health PDF-2011-04-048Marie Curie MCCC-FCO-11-C
6 · The paper itself

Abstract

backgroundA reduced exercise capacity is associated with increased morbidity and mortality in patients with advanced non-small cell lung cancer (NSCLC). Therapeutic exercise can be beneficial and neuromuscular electrical stimulation (NMES) of the quadriceps muscles may represent a practical approach. The primary aim of this study was to determine the acceptability of NMES of the quadriceps to patients with NSCLC used alongside palliative chemotherapy. Secondary aims explored aspects of safety and efficacy of NMES in this setting.

methodsPatients with advanced NSCLC due to receive first-line palliative chemotherapy were randomized to usual care with or without NMES. They were asked to undertake 30 minute sessions of NMES, ideally daily, but as a minimum, three times weekly. For NMES to be considered acceptable, it was predetermined that ≥80% of patients should achieve this minimum level of adherence. Qualitative interviews were held with a subset of patients to explore factors influencing adherence. Safety was assessed according to the Common Terminology Criteria for Adverse Events. Quadriceps muscle strength, thigh lean mass, and physical activity level were assessed at baseline and after three cycles of chemotherapy.

results49 patients (28 male, median (IQR) age 69 (64-75) years) participated. Of 30 randomized to NMES, 18 were eligible for the primary endpoint, of whom 9 (50% [90% CI, 29 to 71]) met the minimum level of adherence. Adherence was enhanced by incorporating sessions into a daily routine and hindered by undesirable effects of chemotherapy. There were no serious adverse events related to NMES, nor significant differences in quadriceps muscle strength, thigh lean mass or physical activity level between groups.

conclusionsNMES is not acceptable in this setting, nor was there a suggestion of benefit. The need remains to explore NMES in patients with cancer in other settings.

trial registrationCurrent Controlled Trials ISRCTN 42944026 www.controlled-trials.com/ISRCTN42944026.

Indexed as

Electric Stimulation TherapyPalliative CareAdrenal Cortex HormonesAgedAntineoplastic Agents, HormonalCarcinoma, Non-Small-Cell LungFemaleHumansLung NeoplasmsMaleMiddle AgedMuscle, SkeletalAdrenal Cortex HormonesAntineoplastic Agents, Hormonal

Identifiers

PMID24386491
PMCPMC3875585
OpenAlexW1974378005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.